Insulet raises full-year Omnipod revenue growth guidance to 29–30% as international momentum accelerates (NASDAQ:PODD)
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...